Hubei Biocause Heilen Pharmaceutical Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Qun Liang
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 4.3yrs |
| CEO ownership | n/a |
| Management average tenure | 4.3yrs |
| Board average tenure | no data |
Recent management updates
Recent updates
CEO
Qun Liang (53 yo)
4.3yrs
Tenure
CN¥394,800
Compensation
Mr. Qun Liang is General Manager of Hubei Biocause Heilen Pharmaceutical Co., Ltd. from June 2020.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| General Manager | 4.3yrs | CN¥394.80k | no data | |
| Financial Director | 4.3yrs | CN¥388.80k | no data | |
| Board Secretary | 2.3yrs | CN¥371.60k | no data | |
| Deputy General Manager | 4.3yrs | CN¥338.30k | no data |
4.3yrs
Average Tenure
51.5yo
Average Age
Experienced Management: 301211's management team is considered experienced (4.3 years average tenure).